查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969903

全球靜脈輸液幫浦市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Intravenous Infusion Pump Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計靜脈輸液幫浦市場將從 2025 年的 68.2 億美元成長到 2034 年的 146.7 億美元，2026 年至 2034 年的複合年成長率為 8.89%。

由於醫院和居家醫療機構對精準控釋藥物的需求日益成長，全球靜脈輸液幫浦市場正穩定成長。靜脈輸液幫浦廣泛用於將液體、藥物和營養物質直接輸送到患者的血液中。隨著外科手術、慢性疾病以及加護病房患者數量的增加，對這些設備的需求顯著成長。此外，人們對病人安全的日益重視也推動了市場成長。

主要促進因素包括糖尿病、癌症和心血管疾病的日益普遍，這些疾病需要持續精確的藥物治療。智慧型輸液幫浦等技術創新，例如配備安全警報、輸液錯誤減少系統和無線連接等功能，正在提高治療效率。居家醫療服務的擴展，尤其是在老年患者群體中，進一步推動了對攜帶式輸液幫浦的需求。醫院也增加對先進設備的投入，以改善病患的治療效果。

未來幾年，隨著醫療保健系統的持續創新和數位化整合，市場預計將持續擴張。互聯設備和數據監測系統的應用將提高治療的準確性，並減少用藥錯誤。在新興市場，隨著醫療基礎設施的擴展，預計將迎來強勁的成長機會。在醫療費用支出不斷成長和技術進步的推動下，靜脈輸液幫浦市場前景廣闊。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球靜脈輸液幫浦市場：依產品分類

  • 市場分析、洞察與預測
  • 正排量輸液泵
  • 注射幫浦
  • 胰島素輸注泵
  • 腸內輸液泵
  • 攜帶式輸液泵
  • 病人管理鎮痛輸注泵
  • 植入式輸液泵
  • 其他

第5章：全球靜脈輸液幫浦市場：依適應症分類

  • 市場分析、洞察與預測
  • 化療
  • 糖尿病
  • 胃腸病學
  • 鎮痛/疼痛管理
  • 小兒科/新生兒科
  • 血液學
  • 其他

第6章 全球靜脈輸液幫浦市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Baxter
    • B. Braun Medical Inc
    • Medtronic
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • Cardinal Health
    • Fresenius Kabi AG
    • ICU Medical Inc
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care Inc
    • Terumo Corporation,
簡介目錄
Product Code: VMR112110631

The Intravenous Infusion Pump Market size is expected to reach USD 14.67 Billion in 2034 from USD 6.82 Billion (2025) growing at a CAGR of 8.89% during 2026-2034.

The Global Intravenous Infusion Pump Market is growing steadily due to the increasing need for accurate and controlled drug delivery in hospitals and homecare settings. Intravenous infusion pumps are widely used to administer fluids, medications, and nutrients directly into a patient's bloodstream. The rising number of surgeries, chronic diseases, and intensive care admissions has significantly increased the demand for these devices. Growing awareness about patient safety is also supporting market growth.

Key drivers include the increasing prevalence of diabetes, cancer, and cardiovascular diseases, which require continuous and precise medication delivery. Technological advancements such as smart infusion pumps with safety alarms, dose error reduction systems, and wireless connectivity are improving treatment efficiency. The growing adoption of home healthcare services, especially among elderly patients, is further boosting demand for portable infusion pumps. Hospitals are increasingly investing in advanced equipment to improve patient outcomes.

In the coming years, the market is expected to expand due to ongoing innovations and digital integration in healthcare systems. The use of connected devices and data monitoring systems will enhance treatment accuracy and reduce medication errors. Emerging markets are likely to offer strong growth opportunities due to expanding healthcare infrastructure. With increasing healthcare expenditure and technological progress, the intravenous infusion pump market has a promising future outlook.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Insulin Infusion Pumps
  • Enteral Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others

By Disease Indication

  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others

COMPANIES PROFILED

  • Baxter, B Braun Medical Inc, Medtronic, Micrel Medical Devices SA, Boston Scientific Corporation, Cardinal Health, Fresenius Kabi AG, ICU Medical Inc, F HoffmannLa Roche Ltd, Tandem Diabetes Care Inc, Terumo Corporation,
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRAVENOUS INFUSION PUMP MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Volumetric Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Syringe Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Insulin Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Enteral Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Ambulatory Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Patient-Controlled Analgesia Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Implantable Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRAVENOUS INFUSION PUMP MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Disease Indication
  • 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Analgesia/Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Pediatrics/Neonatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRAVENOUS INFUSION PUMP MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By Disease Indication
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By Disease Indication
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By Disease Indication
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By Disease Indication
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By Disease Indication
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL INTRAVENOUS INFUSION PUMP INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Baxter
    • 8.2.2 B. Braun Medical Inc
    • 8.2.3 Medtronic
    • 8.2.4 Micrel Medical Devices SA
    • 8.2.5 Boston Scientific Corporation
    • 8.2.6 Cardinal Health
    • 8.2.7 Fresenius Kabi AG
    • 8.2.8 ICU Medical Inc
    • 8.2.9 F. Hoffmann-La Roche Ltd
    • 8.2.10 Tandem Diabetes Care Inc
    • 8.2.11 Terumo Corporation,